An investigation of machine learning algorithms for prediction of lumbar disc herniation.

The prevalence of lumbar disc herniation (LDH), which makes patients' daily activities more difficult and reduces their quality of life, has tended to increase recently. Many risk factors associated with LDH have been reported. In this study, LDH was predicted using machine learning techniques using measures of the lumbar paraspinal muscles, lumbar vessels cross-sectional area (CSA), and lumbar sagittal curve. Three hundred and forty-four individuals' MR scans were prospectively enrolled (264 with LDH and 80 healthy). Predictive factors were the lumbar sagittal curve and the cross-sectional areas of the lumbar paraspinal muscles and vessels from sagittal and axial MR images. The measurements have been analyzed via ten different and most common machine learning algorithms by considering a comprehensive parameter tuning and cross-validation process. The variable importance results have been also presented. XGBoost algorithm among all algorithms has provided the best results in terms of different classification metrics including f-score ([Formula: see text]), AUC ([Formula: see text]), accuracy ([Formula: see text]), and kappa ([Formula: see text]). The findings of this study demonstrated that cross-sectional areas of the quadratus lumborum and abdominal aorta can be utilized as a reliable indicator of LDH. Consequently, the developed model and the variables found to be important may guide to healthcare professionals to make more accurate and effective decisions in terms of prediction the LDH.

Potential Association Between COVID-19 Vaccination and Facial Palsy: Three Cases With Neuroimaging Findings.

Acute onset Facial palsy was reported in four vaccinated participants in the BNT162b2 (Pfizer-BioNTech) vaccine clinical trials published on December 10, 2020. So far, few cases of Facial palsy among the mRNA vaccine groups have been previously documented in the literature. Facial palsy is cited as medically attended adverse event following immunization on April 12, 2021, after the first dose of the approved Pfizer-BioNTech COVID-19 vaccines for preventive immunization for SARS-CoV-2 is administrated to the population in Turkey. This study is aimed to describe clinical and magnetic resonance imaging features of three patients, who developed acute onset peripheral facial paralysis after administration of the BNT162b2 vaccine, without any previous medical condition. The first patient presented with right sided facial palsy within the same day following the vaccine was administrated, while the second patient presented with left sided facial palsy 2 months after vaccination. The third patient, on the other hand, presented with right sided facial palsy and abducens nerve (CN VI) paralysis two days after vaccine was administrated.